Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study

This publication has 29 references indexed in Scilit:

• Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
  BMJ Open, 2013
• Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
  Diabetologia, 2012
• HPV vaccination in France: Uptake, costs and issues for the National Health Insurance
  Vaccine, 2011
• Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation
  Circulation, 2010
• Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus
  Pharmacoepidemiology and Drug Safety, 2010
• Ageing populations: the challenges ahead
  The Lancet, 2009
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
  Blood, 2009
• Ecological association between a deprivation index and mortality in France over the period 1997 – 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death
  BMC Public Health, 2009
• Invited Commentary: Variable Selection versus Shrinkage in the Control of Multiple Confounders
  American Journal of Epidemiology, 2007
• Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
  The Lancet, 1999